Cargando…
Cerebrospinal fluid biomarkers for differentiation of frontotemporal lobar degeneration from Alzheimer's disease
Accurate ante mortem diagnosis in frontotemporal lobar degeneration (FTLD) is crucial to the development and implementation of etiology-based therapies. Several neurodegenerative disease-associated proteins, including the major protein constituents of inclusions in Alzheimer's disease (AD) asso...
Autores principales: | Irwin, David J., Trojanowski, John Q., Grossman, Murray |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3578350/ https://www.ncbi.nlm.nih.gov/pubmed/23440936 http://dx.doi.org/10.3389/fnagi.2013.00006 |
Ejemplares similares
-
Cerebrospinal Fluid Biomarkers in Autopsy-Confirmed Alzheimer Disease and Frontotemporal Lobar Degeneration
por: Mattsson-Carlgren, Niklas, et al.
Publicado: (2022) -
Empiric Methods to Account for Pre-analytical Variability in Digital Histopathology in Frontotemporal Lobar Degeneration
por: Giannini, Lucia A. A., et al.
Publicado: (2019) -
Signature laminar distributions of pathology in frontotemporal lobar degeneration
por: Ohm, Daniel T., et al.
Publicado: (2022) -
Neuron loss and degeneration in the progression of TDP-43 in frontotemporal lobar degeneration
por: Yousef, Ahmed, et al.
Publicado: (2017) -
Genetics of Frontotemporal Lobar Degeneration
por: Galimberti, Daniela, et al.
Publicado: (2012)